Reuters on MSN50m
J&J's oral skin disease drug meets main goals of late-stage studyThe once-daily pill, icotrokinra, was tested in patients with moderate-to-severe plaque psoriasis, a skin condition that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback